About Lifespan Biosciences (LSBio)
Founded in 1995, LSBio (LifeSpan BioSciences) is a molecular pathology-focused life science supplier specialising in antibodies, immunoassays, proteins and related research reagents. The company’s scientific expertise originates from immunohistochemistry (IHC) and protein localisation studies in diseased human tissues, supporting researchers investigating cancer biology, cell signalling, neuroscience, immunology, infectious disease and translational research applications. Its antibody development and validation activities have enabled the creation of extensive reagent collections for use in IHC, immunofluorescence, western blotting, flow cytometry and other protein analysis workflows.
LSBio offers a broad portfolio of monoclonal and polyclonal antibodies, ELISA and immunoassay kits, assay kits, recombinant and native proteins, peptides, lysates and biochemicals. Its proprietary IHC-plus™ antibody range comprises extensively characterised antibodies validated for formalin-fixed, paraffin-embedded tissue applications, while its immunoassay portfolio includes sandwich, competitive, cell-based and DNA-binding ELISA formats for quantitative biomarker and pathway analysis. Complementary assay kits support studies of apoptosis, proliferation, metabolism and other cellular processes, providing tools for both basic and applied research workflows.
Europa Biosite subsidiaries distribute LSBio products in Austria, Belgium, Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Sweden, Switzerland and the United Kingdom.